C. Feumi

970 total citations · 1 hit paper
7 papers, 795 citations indexed

About

C. Feumi is a scholar working on Ophthalmology, Molecular Biology and Neurology. According to data from OpenAlex, C. Feumi has authored 7 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Ophthalmology, 3 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in C. Feumi's work include Retinal Diseases and Treatments (5 papers), Glaucoma and retinal disorders (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). C. Feumi is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Glaucoma and retinal disorders (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). C. Feumi collaborates with scholars based in France, United States and Canada. C. Feumi's co-authors include Florian Sennlaub, William Raoul, Christophe Combadière, Sophie Lavalette, Francine Béhar‐Cohen, Marianne Houssier, Nicole Keller, Laurent Jonet, Sylvain Chemtob and Mirna Sirinyan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Neurobiology of Disease.

In The Last Decade

C. Feumi

7 papers receiving 782 citations

Hit Papers

CX3CR1-dependent subretinal microglia cell accumulation i... 2007 2026 2013 2019 2007 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Feumi France 5 514 342 335 166 137 7 795
P L Penfold Australia 15 730 1.4× 389 1.1× 231 0.7× 148 0.9× 381 2.8× 24 1.1k
Oliver W. Gramlich United States 17 669 1.3× 393 1.1× 183 0.5× 60 0.4× 173 1.3× 40 880
Pablo F. Barcelona Argentina 14 219 0.4× 263 0.8× 63 0.2× 42 0.3× 88 0.6× 29 501
Francisco J. López United States 16 283 0.6× 236 0.7× 44 0.1× 81 0.5× 164 1.2× 24 633
Hiroto Shibuki Japan 10 221 0.4× 409 1.2× 64 0.2× 38 0.2× 70 0.5× 12 600
Richard Foxton United Kingdom 9 461 0.9× 294 0.9× 53 0.2× 52 0.3× 293 2.1× 18 662
Hani Levkovitch-Verbin Israel 18 909 1.8× 509 1.5× 150 0.4× 26 0.2× 457 3.3× 39 1.3k
Lichun Zhong United States 4 555 1.1× 331 1.0× 88 0.3× 23 0.1× 299 2.2× 7 794
Yalan Wu China 9 201 0.4× 286 0.8× 56 0.2× 135 0.8× 90 0.7× 10 630
Toshka A. Abrams United States 14 252 0.5× 470 1.4× 35 0.1× 272 1.6× 54 0.4× 20 738

Countries citing papers authored by C. Feumi

Since Specialization
Citations

This map shows the geographic impact of C. Feumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Feumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Feumi more than expected).

Fields of papers citing papers by C. Feumi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Feumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Feumi. The network helps show where C. Feumi may publish in the future.

Co-authorship network of co-authors of C. Feumi

This figure shows the co-authorship network connecting the top 25 collaborators of C. Feumi. A scholar is included among the top collaborators of C. Feumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Feumi. C. Feumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Feumi, C., et al.. (2020). Long-term Follow-up of 14 Eyes With Bilateral and Multiple Ciliary Body Cysts: Prognosis of this Rare Entity. Journal of Glaucoma. 30(1). e13–e17. 1 indexed citations
2.
An, Na, Laurent Jonet, C. Feumi, et al.. (2011). CCR2/CCL2-mediated inflammation protects photoreceptor cells from amyloid-β-induced apoptosis. Neurobiology of Disease. 42(1). 55–72. 24 indexed citations
3.
Raoul, William, Constance Auvynet, Serge Camelo, et al.. (2010). CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration. Journal of Neuroinflammation. 7(1). 87–87. 90 indexed citations
4.
Raoul, William, et al.. (2010). Rôles des chimiokines dans le développement de la dégénérescence maculaire liée à l’âge. Biologie Aujourd hui. 204(4). 311–319. 3 indexed citations
5.
Raoul, William, C. Feumi, Nicole Keller, et al.. (2008). Lipid-Bloated Subretinal Microglial Cells Are at the Origin of Drusen Appearance in CX3CR1-Deficient Mice. Ophthalmic Research. 40(3-4). 115–119. 56 indexed citations
6.
Leconte, Laurence, Stanislas Ropert, William Raoul, et al.. (2008). Netrin-4 inhibits angiogenesis via binding to neogenin and recruitment of Unc5B. Proceedings of the National Academy of Sciences. 105(34). 12491–12496. 121 indexed citations
7.
Combadière, Christophe, C. Feumi, William Raoul, et al.. (2007). CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. Journal of Clinical Investigation. 117(10). 2920–2928. 500 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026